Models of phage growth and their applicability to phage therapy

Journal of Theoretical Biology

Volumn 227, Issue 1, 2004, Pages 1-11

  Weld, Richard J ^a,b   Butts, Christine ^c   Heinemann, Jack A ^a,b  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

^b New Zealand Inst of Gene Ecology   (New Zealand)

^c THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED   (New Zealand)

Author keywords

Bacteriophage therapy; Growth model; K1 5 phage; T4 phage

Indexed keywords

BACTERIOPHAGE; GROWTH MODELING;

ARTICLE; BACTERIOPHAGE; CONTROLLED STUDY; ESCHERICHIA COLI; MOLECULAR MODEL; NONHUMAN; PREDICTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; THEORETICAL MODEL;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 1142285257     PISSN: 00225193     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5193(03)00262-5     Document Type: Article

References (31)

1. Abedon S.T., Herschler T.D., Stopar D. Bacteriophage latent-period evolution as a response to resource availability. Appl. Environ. Microbiol. 67(9):2001;4233-4241.
2. Adams M. Bacteriophages. 1959;Wiley, New York.
3. Berchieri A., Lovell M.A., Barrow P.A. The activity in the chicken alimentary tract of bacteriophages lytic for Salmonella typhimurium. Res. Microbiol. 142:1991;541-549.
4. Biswas B., Adhya S., Washart P., Paul B., Trostel A.N., Powell B., Carlton R., Merril C.R. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect. Immun. 70(1):2002;204-210.
5. Chanishvili N., Chanishvili T., Tediashvili M., Barrow P.A. Phages and their application against drug-resistant bacteria. J. Chem. Technol. Biotechnol. 76:2001;689-699.
6. Cooper T.F., Heinemann J.A. Transfer of conjugative plasmids and bacteriophage λ occurs in the presence of antibiotics that prevent de novo gene expression. Plasmid. 43:2000;171-175.
7. Delbruck M. Adsorption of bacteriophages under various physiological conditions of the host. J. Gen. Physiol. 23:1940;631-635.
8. Duffy G., Whiting R.C., Sheridan J.J. The effect of a competitive microflora, pH and temperature on the growth kinetics of E. coli O157:H7. Food Microbiol. 16:1999;299-307.
9. Garcia L.R., Molineux I.J. Rate of translocation of bacteriophage T7 DNA across the membranes of E coli. J. Bacteriol. 177(14):1995;4066-4076.
10. Hadas H., Einav M., Fishov I., Zaritsky A. Bacteriophage T4 development depends on the physiology of its host E. coli. Microbiology. 143:1997;179-185.
11. Kasman L.M., Kasman A., Westwater C., Dolan J., Schmidt M.G., Norris J.S. Overcoming the phage replication threshold. a mathematical model with implications for phage therapy J. Virol. 76(11):2002;5557-5564.
12. Koo J., DePaola A., Marshall D. Effect of simulated gastric fluid and bile on survival of Vibrio vulnificus and Vibrio vulnificus. J. Food Prot. 63(12):2000;1665-1669.
13. Kudva I.T., Jelacic S., Tarr P.I., Youderian P., hovde C.J. Biocontrol of E. coli O157 with O157-specific bacteriophages. Appl. Environ. Microbiol. 65(9):1999;3767-3773.
14. Lenski R.E., Levin B.R. Constraints on the coevolution of bacteria and virulent phage. a model, some experiments, and predictions for natural communities Am. Nat. 125(4):1985;585-602.
15. Levin B.R., Bull J.J. Phage therapy revisited. the population biology of a bacterial infection and its treatment with bacteriophage and antibiotics Am. Nat. 147(6):1996;881-898.
16. Levin B.R., Stewart F.M., Chao L. Resource-limited growth, competition, and predation. a model and experimental studies with bacteria and bacteriophage Am. Nat. 111:1977;3-24.
17. Merril C.R., Biswas B., Carlton R., Jensen N.C., Creed G.J., Zullo S., Adhya S. Long-circulating bacteriophage as antimicrobial agents. Proc. Natl Acad. Sci. USA. 93:1996;3188-3192.
18. Middelboe M. Bacterial growth rate and marine virus-host dynamics. Microb. Ecol. 40:2000;114-124.
19. Nakai T., Sugimoto R., Park K.-H., Matsuoka S., Mori K., Nishioka T., Maruyama K. Protective effects of bacteriophage on experimental Lactococcus garvieae infection in yellowtail. Dis. Aquat. Org. 37:1999;33-41.
20. Payne R.J.H., Jansen V.A.A. Phage therapy. the peculiar kinetics of self-replicating pharmaceuticals Clin. Pharmacol. Ther. 68(3):2000;225-230.
21. Payne R.J.H., Jansen V.A.A. Understanding bacteriophage therapy as a density-dependent kinetic process. J. Theor. Biol. 208:2001;37-48.
22. Ramesh V., Fralick J.A., Rolfe R.D. Prevention of Clostridium difficile-induced ileocecitis with bacteriophage. Anaerobe. 5:1999;69-78.
23. Sambrook J., Russell D.W. Molecular cloning. A laboratory manual. 2001;Cold Spring Harbour Laboratory Press, New York.
24. Scholl D., Rogers S., Adhya S., Merril C.R. Bacteriophage K1-5 encodes two different tail fiber proteins, allowing it to infect and replicate on both K1 and K5 strains of E. coli. J. Virol. 75(6):2001;2509-2515.
25. Schrag S.J., Mittler J.E. Host-parasite coexistence. the role of spastial refuges in stabilizing bacteria-phage interactions Am. Nat. 148(2):1996;348-377.
26. Sharp R. Bacteriophages. biology and history J. Chem. Technol. Biotechnol. 76:2001;667-672.
27. Smith H.W., Huggins M.B. Successful treatment of experimental E. coli infections in mice using phage. its general superiority over antibiotics J. Gen. Microbiol. 128:1982;307-318.
28. Smith H.W., Huggins M.B. Effectiveness of phages in treating experimental E. coli diarrhoea in calves, piglets and lambs. J. Gen. Microbiol. 129:1983;2659-2675.
29. Smith H.W., Huggins M.B., Shaw K.M. The control of experimental E. coli diarrhoea in calves by means of bacteriophages. J. Gen. Microbiol. 133:1987;1111-1126.
30. Wang I.-N., Dykhuizen D.E., Slobodkin L.B. The evolution of phage lysis timing. Evol. Ecol. 10:1996;545-558.
31. Youngman P. Lewis K., Salyers A.A., Taber H.W., Wax R.G. Bacterial Resistance to Antimicrobials. 2002;Marcel Dekker, New York and Basel.